North America Organoid Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Organoid Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Organoid Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 The organoid services market is experiencing rapid growth owing to the increasing demand for innovative screening services.

5.2 Market Opportunities

5.2.1 Increasing key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth

5.3 Future Trends

5.3.1 AI-driven automation can revolutionize organoid production and research workflows

5.4 Impact of Drivers and Restraints

6. North America Organoid Market Regional Analysis

6.1 North America Organoid Market Overview

6.2 North America Organoid Market Revenue 2020-2030 (US$ Million)

6.3 North America Organoid Market Forecast Analysis

7. North America Organoid Market Analysis – by Organ Type

7.1 Intestine

7.1.1 Overview
7.1.2 Intestine: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Liver

7.2.1 Overview
7.2.2 Liver: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Stomach

7.3.1 Overview
7.3.2 Stomach: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview
7.4.2 Pancreas: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Lung

7.5.1 Overview
7.5.2 Lung: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Brain

7.6.1 Overview
7.6.2 Brain: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Kidney

7.7.1 Overview
7.7.2 Kidney: North America Organoid Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Organoid Market Analysis – by Application

8.1 Development of Biology Disease

8.1.1 Overview
8.1.2 Development of Biology Disease: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Pathology of infectious Disease

8.2.1 Overview
8.2.2 Pathology of infectious Disease: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Regenerative Medicines

8.3.1 Overview
8.3.2 Regenerative Medicines: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Drug Discovery and Personalized Medicine

8.4.1 Overview
8.4.2 Drug Discovery and Personalized Medicine: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Drug Toxicity and Efficacy Testing

8.5.1 Overview
8.5.2 Drug Toxicity and Efficacy Testing: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Organoid Market Analysis – by Source

9.1 Pluripotent Stem Cell

9.1.1 Overview
9.1.2 Drug Toxicity and Efficacy Testing: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Organ Specific Adult Stem Cell

9.2.1 Overview
9.2.2 Drug Toxicity and Efficacy Testing: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Organoid Market – North America Analysis

10.1 North America

10.1.1 North America Organoid Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Organoid Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Organoid Market Breakdown, by Organ Type
10.1.1.1.2 US: North America Organoid Market Breakdown, by Application
10.1.1.1.3 US: North America Organoid Market Breakdown, by Source

10.1.1.2 Canada: North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Organoid Market Breakdown, by Organ Type
10.1.1.2.2 Canada: North America Organoid Market Breakdown, by Application
10.1.1.2.3 Canada: North America Organoid Market Breakdown, by Source

10.1.1.3 Mexico : North America Organoid Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Organoid Market Breakdown, by Organ Type
10.1.1.3.2 Mexico : North America Organoid Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Organoid Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Organoid Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 STEMCELL Technologies Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Cellesce

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Organoid Therapeutics

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 3Dnamics Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Thermo Fisher Scientific Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 InSphero

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights